Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

£2.6m for radical new treatment for kidney dialysis patients

15.02.2006


An innovative new medical approach which could substantially improve the quality of life for over a million kidney dialysis patients, and bring huge savings to health services around the globe has received an investment round worth £2.6m.



The development of this new product has been made possible thanks to a major funding round of £2.6m led by NPI Ventures with funding from NESTA (the National Endowment for Science, Technology and the Arts), who had previously invested £95,000 in the technology, Imperial College and Oxford Capital Partners.

At present, over a million kidney dialysis patients worldwide are treated by having a synthetic tube – called a vascular access graft - inserted under the skin, through which they are "hooked up" to a machine every few days.


Vascular access grafts are inserted beneath the skin so needles can be injected regularly and to maximise blood-flow to the dialysis machine. However, these can develop a potentially lethal disease, called ‘intimal hyperplasia’. This thickens the blood vessels, which is the most common reason for grafts needing to be replaced within a year, or for patients to undergo remedial surgery.

London-based Veryan Medical Ltd has developed SwirlGraft to combat this. It updates the standard synthetic grafts with a new spiral shape, allowing the blood to swirl through it, mimicking its natural action and reducing the likelikood of any problems.

By ensuring appropriate swirling blood flow through the dialysis graft and into the downstream vein, it stands to greatly reduce the disease by eliminating the stagnant flow regions where ‘intimal hyperplasia’ proliferates.

The SwirlGraft vascular access graft has undergone clinical trials at six hospitals in the Netherlands. During 2005 SwirlGraft was granted regulatory approvals in the US and Europe. This funding round will be used to develop the SwirlGraft and in particular to finance further clinical trials for the US market. The investment includes an option for a further £5.2m investment to further develop Veryan’s next high value product, the SwirlFlow vascular stent.

Mark White , Director of Invention & Innovation at NESTA, said:

"Veryan Medical is a great example of the kind of UK innovation our early stage seed funding is designed to support. Through investing in its innovative technology early on we are looking to ensure that this idea has every opportunity of being fully commercialised, benefiting patients, those working in healthcare, and the UK economy."

Joseph Meaney | alfa
Further information:
http://www.nesta.org.uk

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>